Health Discovery Corporation (HDVY)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 1.74 Million USD | 21.01% |
| 2019 | 1.44 Million USD | 76.96% |
| 2018 | 813.92 Thousand USD | -10.02% |
| 2017 | 904.55 Thousand USD | -9.33% |
| 2016 | 997.63 Thousand USD | 18.03% |
| 2015 | 845.24 Thousand USD | -14.94% |
| 2014 | 993.67 Thousand USD | -56.9% |
| 2013 | 2.3 Million USD | -32.64% |
| 2012 | 3.42 Million USD | 9.22% |
| 2011 | 3.13 Million USD | -39.49% |
| 2010 | 5.17 Million USD | 150.25% |
| 2009 | 2.06 Million USD | -7.69% |
| 2008 | 2.24 Million USD | -11.41% |
| 2007 | 2.53 Million USD | -6.22% |
| 2006 | 2.69 Million USD | -18.14% |
| 2005 | 3.29 Million USD | 49.52% |
| 2004 | 2.2 Million USD | 860.22% |
| 2003 | 229.64 Thousand USD | -35.56% |
| 2002 | 356.34 Thousand USD | 2.85% |
| 2001 | 346.47 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | 494 Thousand USD | -70.42% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 378 Thousand USD | 6.48% |
| 2021 Q2 | 1.67 Million USD | 341.8% |
| 2020 Q4 | 355 Thousand USD | 22.41% |
| 2020 FY | 1.74 Million USD | 21.01% |
| 2020 Q2 | 774 Thousand USD | 140.09% |
| 2020 Q1 | 322.38 Thousand USD | 128.07% |
| 2020 Q3 | 290 Thousand USD | -62.53% |
| 2019 Q4 | 141.35 Thousand USD | -38.0% |
| 2019 FY | 1.44 Million USD | 76.96% |
| 2019 Q2 | 894 Thousand USD | 403.02% |
| 2019 Q3 | 228 Thousand USD | -74.5% |
| 2019 Q1 | 177.72 Thousand USD | -17.01% |
| 2018 Q3 | 207.69 Thousand USD | 5.65% |
| 2018 FY | 813.92 Thousand USD | -10.02% |
| 2018 Q1 | 195.49 Thousand USD | 0.0% |
| 2018 Q2 | 196.58 Thousand USD | 0.56% |
| 2018 Q4 | 214.15 Thousand USD | 3.11% |
| 2017 FY | 904.55 Thousand USD | -9.33% |
| 2016 FY | 997.63 Thousand USD | 18.03% |
| 2016 Q4 | 198.05 Thousand USD | -14.43% |
| 2016 Q3 | 231.44 Thousand USD | -26.92% |
| 2016 Q2 | 316.71 Thousand USD | 25.97% |
| 2016 Q1 | 251.42 Thousand USD | 32.22% |
| 2015 Q1 | 244.18 Thousand USD | 22.16% |
| 2015 FY | 845.24 Thousand USD | -14.94% |
| 2015 Q4 | 190.15 Thousand USD | -3.28% |
| 2015 Q3 | 196.6 Thousand USD | -8.26% |
| 2015 Q2 | 214.31 Thousand USD | -12.23% |
| 2014 Q2 | 244.44 Thousand USD | -23.59% |
| 2014 Q3 | 229.41 Thousand USD | -6.15% |
| 2014 FY | 993.67 Thousand USD | -56.9% |
| 2014 Q4 | 199.89 Thousand USD | -12.87% |
| 2014 Q1 | 319.93 Thousand USD | -30.49% |
| 2013 Q4 | 460.28 Thousand USD | 1.39% |
| 2013 Q1 | 699.42 Thousand USD | -28.77% |
| 2013 Q3 | 453.94 Thousand USD | -34.4% |
| 2013 Q2 | 692.02 Thousand USD | -1.06% |
| 2013 FY | 2.3 Million USD | -32.64% |
| 2012 FY | 3.42 Million USD | 9.22% |
| 2012 Q1 | 901.39 Thousand USD | 1.75% |
| 2012 Q3 | 721.9 Thousand USD | -11.69% |
| 2012 Q2 | 817.5 Thousand USD | -9.31% |
| 2012 Q4 | 981.96 Thousand USD | 36.02% |
| 2011 Q2 | 723.32 Thousand USD | -14.12% |
| 2011 Q4 | 885.91 Thousand USD | 29.81% |
| 2011 Q3 | 682.44 Thousand USD | -5.65% |
| 2011 FY | 3.13 Million USD | -39.49% |
| 2011 Q1 | 842.25 Thousand USD | -56.98% |
| 2010 Q2 | 1.13 Million USD | 6.16% |
| 2010 FY | 5.17 Million USD | 150.25% |
| 2010 Q3 | 993.1 Thousand USD | -12.67% |
| 2010 Q4 | 1.95 Million USD | 97.15% |
| 2010 Q1 | 1.07 Million USD | 239.08% |
| 2009 Q4 | 315.92 Thousand USD | -49.31% |
| 2009 Q1 | 572.18 Thousand USD | 17.08% |
| 2009 Q2 | 558.41 Thousand USD | -2.41% |
| 2009 Q3 | 623.27 Thousand USD | 11.62% |
| 2009 FY | 2.06 Million USD | -7.69% |
| 2008 Q3 | 640.7 Thousand USD | 21.69% |
| 2008 Q1 | 586.25 Thousand USD | -0.65% |
| 2008 FY | 2.24 Million USD | -11.41% |
| 2008 Q4 | 488.69 Thousand USD | -23.72% |
| 2008 Q2 | 526.52 Thousand USD | -10.19% |
| 2007 Q2 | 647.14 Thousand USD | 10.33% |
| 2007 FY | 2.53 Million USD | -6.22% |
| 2007 Q4 | 590.07 Thousand USD | -17.72% |
| 2007 Q3 | 717.15 Thousand USD | 10.82% |
| 2007 Q1 | 586.56 Thousand USD | 39.93% |
| 2006 Q3 | 428.12 Thousand USD | -20.07% |
| 2006 Q4 | 419.19 Thousand USD | -2.09% |
| 2006 FY | 2.69 Million USD | -18.14% |
| 2006 Q1 | 1.31 Million USD | 113.5% |
| 2006 Q2 | 535.64 Thousand USD | -59.3% |
| 2005 Q4 | 616.36 Thousand USD | -33.28% |
| 2005 FY | 3.29 Million USD | 49.52% |
| 2005 Q1 | 927.92 Thousand USD | -6.26% |
| 2005 Q2 | 829 Thousand USD | -10.66% |
| 2005 Q3 | 923.78 Thousand USD | 11.43% |
| 2004 Q4 | 989.86 Thousand USD | 88.44% |
| 2004 Q3 | 525.29 Thousand USD | 22.99% |
| 2004 Q2 | 427.12 Thousand USD | 58.61% |
| 2004 Q1 | 269.29 Thousand USD | 133.61% |
| 2004 FY | 2.2 Million USD | 860.22% |
| 2003 Q3 | 55.56 Thousand USD | 93.66% |
| 2003 Q4 | 115.27 Thousand USD | 107.45% |
| 2003 Q2 | 28.69 Thousand USD | -5.33% |
| 2003 FY | 229.64 Thousand USD | -35.56% |
| 2003 Q1 | 30.31 Thousand USD | -68.09% |
| 2002 Q2 | 97.37 Thousand USD | 54.46% |
| 2002 Q4 | 94.98 Thousand USD | -5.93% |
| 2002 Q3 | 100.97 Thousand USD | 3.7% |
| 2002 FY | 356.34 Thousand USD | 2.85% |
| 2002 Q1 | 63.03 Thousand USD | -81.12% |
| 2001 FY | 346.47 Thousand USD | 0.0% |
| 2001 Q3 | 5963.00 USD | 0.0% |
| 2001 Q4 | 333.87 Thousand USD | 5499.03% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Achiko AG | 6.78 Million USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | 8.04 Million USD | 100.0% |
| Cannabis Sativa, Inc. | 862.24 Thousand USD | 100.0% |
| CompuMed, Inc. | 2.91 Million USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 100.0% |
| Cogstate Limited | 23.64 Million USD | 100.0% |
| CareView Communications, Inc. | 7.21 Million USD | 100.0% |
| Craneware plc | 141.35 Million USD | 100.0% |
| Caduceus Software Systems Corp. | 2.07 Million USD | 100.0% |
| Certive Solutions Inc. | 1.5 Million USD | 100.0% |
| Drug Free Solution, Inc. | 1.39 Million USD | 100.0% |
| DATATRAK International, Inc. | 3.26 Million USD | 100.0% |
| Strainsforpains, Inc. | 149.72 Thousand USD | 100.0% |
| Healixa Inc. | 6.56 Million USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | 3.28 Million USD | 100.0% |
| Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | 491.28 USD | 100.0% |
| IQ-AI Limited | 1.13 Million USD | 100.0% |
| Cannabiz Mobile, Inc. | 750.00 USD | 100.0% |
| Mednow Inc. | 2.78 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | 270.72 Thousand USD | 100.0% |
| MediXall Group, Inc. | 59.26 Thousand USD | 100.0% |
| Mitesco, Inc. | 2.58 Million USD | 100.0% |
| MobileSmith, Inc. | 8.63 Million USD | 100.0% |
| NantHealth, Inc. | 94.47 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | 1.76 Million USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | 12.38 Million USD | 100.0% |
| Patient Access Solutions, Inc. | 9.19 Million USD | 100.0% |
| Pharma-Bio Serv, Inc. | 3.94 Million USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | 100.0% |
| Renalytix Plc | 29.04 Million USD | 100.0% |
| Revium Recovery Inc. | 677 Thousand USD | 100.0% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | 369.00 USD | 100.0% |
| Vaso Corporation | 46.39 Million USD | 100.0% |
| Vynleads, Inc. | 200.15 Thousand USD | 100.0% |